Copyright
©The Author(s) 2024.
World J Stem Cells. May 26, 2024; 16(5): 486-498
Published online May 26, 2024. doi: 10.4252/wjsc.v16.i5.486
Published online May 26, 2024. doi: 10.4252/wjsc.v16.i5.486
Figure 3 Sinomenine promotes osteogenic differentiation of bone marrow mesenchymal stromal cells but can be reversed by 3-methyladenine.
A: Representative images of ALP staining at 7 d; B: Representative images of Alizarin red S (ARS) staining at 21 d; C and D: Quantitative analysis of ALP activity and the ARS recovery ratio; E-H: Protein levels of ALP, RUNX2 and COL1A1 after sinomenine (SIN) and 3-methyladenine treatment for five days; I-K: Runx2, ALP and COL1A1 mRNA levels after SIN treatment for five days. n = 3 per group. The three groups were cultured in osteogenic medium, and the values are shown as the mean ± SD. aP < 0.01, all data were normalized relative to the sham bone marrow mesenchymal stromal cell group. OVX: Ovariectomized; SIN: Sinomenine; 3-MA: 3-methyladenine; BMSC: Bone marrow mesenchymal stromal cell.
- Citation: Xiao HX, Yu L, Xia Y, Chen K, Li WM, Ge GR, Zhang W, Zhang Q, Zhang HT, Geng DC. Sinomenine increases osteogenesis in mice with ovariectomy-induced bone loss by modulating autophagy. World J Stem Cells 2024; 16(5): 486-498
- URL: https://www.wjgnet.com/1948-0210/full/v16/i5/486.htm
- DOI: https://dx.doi.org/10.4252/wjsc.v16.i5.486